American Association of Endocrine Surgeons Guidelines for AdrenalectomyLinwah Yip, Nancy D. Perrier, James A. Lee et al.|JAMA Surgery|2022Cited by 224
Phase 2 study of pembrolizumab in patients with advanced rare cancersAung Naing, Mouhammed Amir Habra, Funda Meric‐Bernstam et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 130
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor HypoxiaRodrigo A. Toledo, Patricia L. M. Dahia, Camilo Jiménez et al.|Endocrine Reviews|2022Cited by 86
A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current LiteratureMinas P. Economides, Matthew T. Campbell, Amishi Y. Shah et al.|Frontiers in Endocrinology|2020Cited by 18
Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid CarcinomaSarah Hamidi, Steven G. Waguespack, Sireesha Yedururi et al.|Thyroid|2024Cited by 9